The Anaphylaxis UK 2023 Business Symposium, is a landmark event in the world of food safety, bringing together professionals from all corners of the food industry.

A collaboration between Camallergy and OnDosis promises to usher in a new era in food allergy treatment, combining cutting-edge technology with patient-centric care.

ALK has obtained acceptance from the MHRA to extend the use of specific lot (batch) numbers of Jext® 150 mcg and Jext® 300 mcg auto-injectors, beyond the labelled expiry date by two months.

Anaphylaxis UK is deeply saddened to learn of the death of Robin Wynne Williams, a 45-year-old construction engineer who tragically died from anaphylaxis due to a severe food allergy. Senior coroner Kate Robertson has ended the inquest into Robin’s death

Anaphylaxis UK will be taking part in the Big Give’s Christmas Challenge 2023. From midday 28 November to midday 5 December 2023, donations to our Big Give campaign page will be matched by our supporters The Hospital Saturday Fund. Twice the donation, twice the impact.

The biopharmaceutical company DBV Technologies is due to begin two safety trials for Viaskin Peanut in two age groups, known as COMFORT Toddlers and COMFORT Children.

An employee who was sacked after taking five days off work to recover from a near-fatal allergic reaction has successfully sued his employer on the grounds of disability discrimination.

A community pharmacist in Co Down, Northern Ireland, has been celebrated as a local hero after treating a woman with adrenaline after a bee sting caused an anaphylactic reaction

Researchers based at Birmingham Heartlands Hospital are inviting health professionals to take part in The FAIR Study to benefit patients from a South Asian Background with food allergies.